Fig. 4.
Fig. 4. Schematic diagram of dileucine internalization motif. The extracellular (EX), transmembrane (TM) and intracellular (ID) domains are indicated for gp130 and the wild-type (WT) and mutant ▵716 G-CSFR forms. A dileucine motif (underlined) that modulates ligand internalization and receptor expression localizes to the distal region of box 3 in gp130. An identical motif is present in the WT G-CSFR (underlined). Mutations in the critical region in patients with SCN/AML as in the ▵716 mutation result in the introduction of a premature stop codon (STOP) and deletion of the carboxy-terminal tail of the G-CSFR (diagonal lines) within which lies the dileucine motif (underlined).

Schematic diagram of dileucine internalization motif. The extracellular (EX), transmembrane (TM) and intracellular (ID) domains are indicated for gp130 and the wild-type (WT) and mutant ▵716 G-CSFR forms. A dileucine motif (underlined) that modulates ligand internalization and receptor expression localizes to the distal region of box 3 in gp130. An identical motif is present in the WT G-CSFR (underlined). Mutations in the critical region in patients with SCN/AML as in the ▵716 mutation result in the introduction of a premature stop codon (STOP) and deletion of the carboxy-terminal tail of the G-CSFR (diagonal lines) within which lies the dileucine motif (underlined).

Close Modal

or Create an Account

Close Modal
Close Modal